In our case, our company has benefited immensely from the SR&ED program. When finances are tight, there's often a tendency to perhaps look at reducing investments in longer-term, longer-return programs in order to allocate funds to things that could demonstrate returns more quickly. But I think the important thing to note is that innovation is the activity, which then feeds into the commercialization process. So if you begin to reduce funding or support on the innovation side, you may see an explosion of commercialization in the short term, but eventually the process that feeds the commercialization activity will dry up. From our perspective, it's equally important to both continue funding the longer-term innovation or research activities and increase funding to commercialization activities.
On October 18th, 2011. See this statement in context.